ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

NCI Approved CTEP Trials For the Month of August

August 31, 2012